NDA (New Drug Application)
ANDA (Generic Application)
It is formulated by 1 pharmaceutical company such as PFIZER. It is marketed under 1 brand name, including CIBINQO. Available in 3 different strengths, such as 50MG, 100MG, 200MG, and administered through 1 route including TABLET;ORAL.
Track protection status across key markets to assess launch feasibility.
API availability: Loading API feasibility...
Licensing: 1 potential partnersUS Launch window: Loading launch window...
FDA approval history for this ingredient
Key expiration dates for US patents covering this ingredient
Latest drug strengths approved by FDA
| Strength | Route of Administration | Companies | Latest Approval Date |
|---|
Patents approved by the FDA for the ingredient
|
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
|---|---|---|---|---|---|
| {"application_id":"91611","ingredient":"ABROCITINIB","trade_name":"CIBINQO","family_id":"e394c28443e74896ad20","publication_number":"US9035074B2","cleaned_patent_number":"9035074","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-19","publication_date":"2015-05-19","legal_status":"Granted"} | US9035074B2 Molecular Formulation | 19 May, 2015 | Granted | 19 Feb, 2034 | |
| {"application_id":"91612","ingredient":"ABROCITINIB","trade_name":"CIBINQO","family_id":"e394c28443e74896ad20","publication_number":"US9545405B2","cleaned_patent_number":"9545405","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-19","publication_date":"2017-01-17","legal_status":"Granted"} | US9545405B2 Molecular Formulation | 17 Jan, 2017 | Granted | 19 Feb, 2034 | |
| {"application_id":"91554","ingredient":"ABROCITINIB","trade_name":"CIBINQO","family_id":"e394c28443e74896ad20","publication_number":"US9549929B2","cleaned_patent_number":"9549929","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-19","publication_date":"2017-01-24","legal_status":"Granted"} | US9549929B2 | 24 Jan, 2017 | Granted | 19 Feb, 2034 |
Latest clinical trials and research studies for this ingredient
| NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
|---|
Manufacturing Locations
No suppliers found.
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.